Home / SANN.SW : SIX

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does SANN.SW make money? Does SANN.SW have pricing power? What's the Earnings Whisper? Will SANN.SW profit more as the business scales? What is SANN.SW's management track record? Is SANN.SW's current price justified?

Santhera Pharmaceuticals Holding AG

CHF 15.58 +$3.44 (+28.34%)

SIX · 15 Sep 2026 15:30 UTC

Previous Close

CHF 15.56

Day Range

CHF 15.3CHF 15.92

Year Range

CHF 9.38CHF 18.84

Market Cap

231.07M

AVG Volume

72.43K

Trailing/Forward PE

-4.08/91.65

PEG ratio

0.04

Dividend Yield

Next Earnings Date

2026-09-21

Primary Exchange

Swiss Exchange

Revenue (CHF)

SANN.SW Revenue (CHF) by quarter
Period	Revenue (CHF)
25 Q4	53.17M
25 Q2	24.01M
24 Q4	25M
24 Q2	14.11M
23 Q4	99.44M
23 Q2	3.94M
22 Q4	1.22M
22 Q2	6.25M
21 Q4	-6.09M
21 Q2	4.49M

Net Income (CHF)

SANN.SW Net Income (CHF) by quarter
Period	Net Income (CHF)
25 Q4	-10.4M
25 Q2	-38.83M
24 Q4	-26.71M
24 Q2	-15.26M
23 Q4	78.12M
23 Q2	-23.34M
22 Q4	-41.35M
22 Q2	-29.72M
21 Q4	-35.01M
21 Q2	-20.52M

Operating Income (CHF)

SANN.SW Operating Income (CHF) by quarter
Period	Operating Income (CHF)
25 Q4	-2.37M
25 Q2	-35.44M
24 Q4	-15.59M
24 Q2	-17.74M
23 Q4	70.85M
23 Q2	-20.34M
22 Q4	-20.32M
22 Q2	-25.55M
21 Q4	-37.69M
21 Q2	-19.45M

EBITDA (CHF)

SANN.SW EBITDA (CHF) by quarter
Period	EBITDA (CHF)
25 Q4	480K
25 Q2	-31.12M
24 Q4	-1.4M
24 Q2	-14.97M
23 Q4	92.75M
23 Q2	-13.58M
22 Q4	-27.82M
22 Q2	-18.96M
21 Q4	-27.56M
21 Q2	-7.01M

Cash Flows (CHF)

SANN.SW Cash Flows (CHF) by quarter
Period	Cash Flows (CHF)
25 Q4	-14.22M
25 Q2	-20.6M
24 Q4	-20.32M
24 Q2	-15.36M
23 Q4	62.54M
23 Q2	-15.36M
22 Q4	-21.84M
22 Q2	-11.96M
21 Q4	-18.72M
21 Q2	-18.65M

EPS (CHF)

SANN.SW EPS (CHF) by quarter
Period	EPS (CHF)
25 Q4	-0.78
25 Q2	-3.04
24 Q4	-2.34
24 Q2	-1.35
23 Q4	7
23 Q2	-2.09
22 Q4	-6.43
22 Q2	-5.24
21 Q4	-7.06
21 Q2	-9.22

Expenses (CHF)

SANN.SW Expenses (CHF) by quarter
Period	Expenses (CHF)
25 Q4	25.35M
25 Q2	27.06M
24 Q4	30.01M
24 Q2	26.77M
23 Q4	27.37M
23 Q2	6.69M
22 Q4	23.47M
22 Q2	29.62M
21 Q4	29.53M
21 Q2	21.58M

Cash & Debt (CHF)

SANN.SW Cash & Debt (CHF) by quarter
Period	Cash & Debt (CHF)
25 Q4	22.44M
25 Q2	18.4M
24 Q4	40.92M
24 Q2	16.49M
23 Q4	30.37M
23 Q2	1.67M
22 Q4	1.35M
22 Q2	12.7M
21 Q4	21.21M
21 Q2	7.99M

Debt ratios

SANN.SW Debt ratios by quarter
Period	Debt ratios
25 Q4	-1.6
25 Q2	1.28
24 Q4	0
24 Q2	0.27
23 Q4	-0.23
23 Q2	-0.45
22 Q4	-0.53
22 Q2	-0.35
21 Q4	-0.25
21 Q2	-0.8

Margins

SANN.SW Margins by quarter
Period	Margins
25 Q4	43.11%
25 Q2	-35.21%
24 Q4	57.37%
24 Q2	63.05%
23 Q4	98.35%
23 Q2	43.29%
22 Q4	-65.82%
22 Q2	65.25%
21 Q4	133.61%
21 Q2	46.46%

Return on Capital

SANN.SW Return on Capital by quarter
Period	Return on Capital
25 Q4	88.05%
25 Q2	1515.1%
24 Q4	-96.44%
24 Q2	-31.76%
23 Q4	130.32%
23 Q2	54.57%
22 Q4	94.66%
22 Q2	214.69%
21 Q4	-2636.07%
21 Q2	-245.65%

Shares Outstanding

SANN.SW Shares Outstanding by quarter
Period	Shares Outstanding
25 Q4	13.39M
25 Q2	12.78M
24 Q4	11.4M
24 Q2	11.34M
23 Q4	11.16M
23 Q2	11.16M
22 Q4	6.44M
22 Q2	5.67M
21 Q4	4.96M
21 Q2	2.22M

Book Value Per Share (CHF)

SANN.SW Book Value Per Share (CHF) by quarter
Period	Book Value Per Share (CHF)
25 Q4	-0.88
25 Q2	-0.2
24 Q4	2.43
24 Q2	4.24
23 Q4	5.37
23 Q2	-3.83
22 Q4	-6.79
22 Q2	-2.44
21 Q4	0.27
21 Q2	3.76

Total Assets (CHF)

SANN.SW Total Assets (CHF) by quarter
Period	Total Assets (CHF)
25 Q4	148.09M
25 Q2	130.77M
24 Q4	152.49M
24 Q2	108.25M
23 Q4	109.63M
23 Q2	63.08M
22 Q4	63.73M
22 Q2	79.78M
21 Q4	91.12M
21 Q2	80.22M

PE Ratio

SANN.SW PE Ratio by quarter
Period	PE Ratio
Sep 25	9.66
Sep 25	12.64
Sep 25	13.15
Sep 25	12.67
Aug 25	12.28
Aug 25	12.89
Aug 25	12.17
Aug 25	11.66
Jul 25	13.26
Jul 25	12.64
Jul 25	12.46
Jul 25	10.86
Jul 25	10.71
Jun 25	10.66
Jun 25	10.5
Jun 25	10.86
Jun 25	12.33
May 25	11.6
May 25	10.98
May 25	11.44
May 25	11.73
May 25	13.06
Apr 25	13.21
Apr 25	12.64
Apr 25	11.41
Apr 25	11.44
Sep 11	1.5
Sep 11	1.64
Sep 11	1.78
Sep 11	1.75
Aug 11	1.75
Aug 11	1.75
Aug 11	1.46
Aug 11	1.48
Jul 11	1.86
Jul 11	1.87
Jul 11	2.17
Jul 11	2.25
Jul 11	2.18
Jun 11	2.24
Jun 11	2.24
Jun 11	2.12
Jun 11	2.12
May 11	2.12
May 11	2.12
May 11	2
May 11	1.79
Apr 11	1.72
Apr 11	1.71
Apr 11	1.77
Apr 11	1.78
Apr 11	1.84

Free Cash Flow Yield

SANN.SW Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-33.82%
Sep 26	-33.4%
Sep 26	-33.57%
Aug 26	-34.13%
Aug 26	-31.63%
Aug 26	-33.18%
Aug 26	-33.23%
Jul 26	-37.17%
Jul 26	-35.32%
Jul 26	-34.13%
Jul 26	-34.58%
Jul 26	-35.56%
Jun 26	-33.27%
Jun 26	-33.02%
Jun 26	-33.74%
Jun 26	-30.89%
May 26	-32.29%
May 26	-33.65%
May 26	-30.6%
May 26	-30.74%
Apr 26	-30.96%
Apr 26	-31.07%
Apr 26	-29.87%
Apr 26	-31.63%
Apr 26	-32.69%
Mar 26	3.23%
Mar 26	3.47%
Mar 26	3.17%
Mar 26	3.2%
Feb 26	2.9%
Feb 26	3.06%
Feb 26	3.01%
Feb 26	3.73%
Jan 26	3.88%
Jan 26	3.54%
Jan 26	3.92%
Jan 26	3.33%
Dec 25	3.89%
Dec 25	3.8%
Dec 25	3.97%
Dec 25	4.02%
Dec 25	4.02%
Nov 25	4.02%
Nov 25	4.04%
Nov 25	4.62%
Nov 25	4.8%
Oct 25	4.8%
Oct 25	4.85%
Oct 25	4.71%
Oct 25	4.73%
Oct 25	4.54%
Sep 25	9.29%
Sep 25	7.11%
Sep 25	6.83%
Sep 25	7.09%
Aug 25	7.31%
Aug 25	6.97%
Aug 25	7.38%
Aug 25	7.7%
Jul 25	6.77%
Jul 25	7.11%
Jul 25	7.21%
Jul 25	8.27%
Jul 25	8.38%
Jun 25	8.42%
Jun 25	8.55%
Jun 25	8.27%
Jun 25	7.28%
May 25	7.74%
May 25	8.18%
May 25	7.85%
May 25	7.66%
May 25	6.88%
Apr 25	6.8%
Apr 25	7.11%
Apr 25	7.87%
Apr 25	7.85%
Mar 25	5.91%
Mar 25	5.89%
Mar 25	5.87%
Mar 25	5.84%
Feb 25	5.42%
Feb 25	5.48%
Feb 25	5.37%
Feb 25	5.33%
Jan 25	5.14%
Jan 25	5.8%
Jan 25	6.29%
Jan 25	6.44%
Jan 25	6.09%
Dec 24	6.93%
Dec 24	8.42%
Dec 24	9.52%
Dec 24	10.95%
Nov 24	10.74%
Nov 24	11.01%
Nov 24	10.61%
Nov 24	10.18%
Nov 24	10.04%
Oct 24	9.69%

Price to Sales

SANN.SW Price to Sales by quarter
Period	Price to Sales
Sep 26	1.79
Sep 26	1.81
Sep 26	1.81
Aug 26	1.78
Aug 26	1.92
Aug 26	1.83
Aug 26	1.82
Jul 26	1.63
Jul 26	1.72
Jul 26	1.78
Jul 26	1.75
Jul 26	1.7
Jun 26	1.82
Jun 26	1.84
Jun 26	1.8
Jun 26	1.96
May 26	1.88
May 26	1.8
May 26	1.98
May 26	1.97
Apr 26	1.96
Apr 26	1.95
Apr 26	2.03
Apr 26	1.92
Apr 26	1.85
Mar 26	1.19
Mar 26	1.11
Mar 26	1.21
Mar 26	1.2
Feb 26	1.33
Feb 26	1.26
Feb 26	1.28
Feb 26	1.03
Jan 26	0.99
Jan 26	1.09
Jan 26	0.98
Jan 26	1.16
Dec 25	0.99
Dec 25	1.01
Dec 25	0.97
Dec 25	0.96
Dec 25	0.96
Nov 25	0.96
Nov 25	0.95
Nov 25	0.83
Nov 25	0.8
Oct 25	0.8
Oct 25	0.79
Oct 25	0.82
Oct 25	0.81
Oct 25	0.85
Sep 25	0.87
Sep 25	1.14
Sep 25	1.18
Sep 25	1.14
Aug 25	1.1
Aug 25	1.16
Aug 25	1.09
Aug 25	1.05
Jul 25	1.19
Jul 25	1.14
Jul 25	1.12
Jul 25	0.98
Jul 25	0.96
Jun 25	0.96
Jun 25	0.94
Jun 25	0.98
Jun 25	1.11
May 25	1.04
May 25	0.99
May 25	1.03
May 25	1.05
May 25	1.17
Apr 25	1.19
Apr 25	1.14
Apr 25	1.03
Apr 25	1.03
Mar 25	1.42
Mar 25	1.43
Mar 25	1.43
Mar 25	1.44
Feb 25	1.55
Feb 25	1.54
Feb 25	1.57
Feb 25	1.58
Jan 25	1.63
Jan 25	1.45
Jan 25	1.34
Jan 25	1.31
Jan 25	1.38
Dec 24	1.21
Dec 24	1
Dec 24	0.88
Dec 24	0.77
Nov 24	0.78
Nov 24	0.76
Nov 24	0.79
Nov 24	0.83
Nov 24	0.84
Oct 24	0.87

EV/EBITDA

SANN.SW EV/EBITDA by quarter
Period	EV/EBITDA
Mar 26	5.57
Mar 26	5.27
Mar 26	5.64
Mar 26	5.6
Feb 26	6.05
Feb 26	5.8
Feb 26	5.88
Feb 26	4.99
Jan 26	4.85
Jan 26	5.19
Jan 26	4.81
Jan 26	5.43
Dec 25	4.84
Dec 25	4.92
Dec 25	4.76
Dec 25	4.72
Dec 25	4.72
Nov 25	4.72
Nov 25	4.71
Nov 25	4.27
Nov 25	4.16
Oct 25	4.16
Oct 25	4.13
Oct 25	4.22
Oct 25	4.2
Oct 25	4.33
Sep 25	1.97
Sep 25	2.58
Sep 25	2.69
Sep 25	2.59
Aug 25	2.51
Aug 25	2.63
Aug 25	2.49
Aug 25	2.38
Jul 25	2.71
Jul 25	2.58
Jul 25	2.54
Jul 25	2.22
Jul 25	2.19
Jun 25	2.18
Jun 25	2.15
Jun 25	2.22
Jun 25	2.52
May 25	2.37
May 25	2.24
May 25	2.34
May 25	2.4
May 25	2.67
Apr 25	2.7
Apr 25	2.58
Apr 25	2.33
Apr 25	2.34
Mar 25	4.91
Mar 25	4.93
Mar 25	4.94
Mar 25	4.97
Feb 25	5.34
Feb 25	5.28
Feb 25	5.38
Feb 25	5.42
Jan 25	5.6
Jan 25	5
Jan 25	4.63
Jan 25	4.53
Jan 25	4.78
Dec 24	4.23
Dec 24	3.53
Dec 24	3.15
Dec 24	2.78
Nov 24	2.83
Nov 24	2.76
Nov 24	2.86
Nov 24	2.97
Nov 24	3
Oct 24	3.1
Oct 24	3.13
Oct 24	3.12
Oct 24	3.09
Sep 24	2.82
Sep 24	2.95
Sep 24	2.92
Sep 24	2.95
Aug 24	2.87
Aug 24	2.87
Aug 24	2.8
Aug 24	2.9
Aug 24	2.82
Jul 24	2.95
Jul 24	2.99
Jul 24	2.66
Jul 24	2.63
Jun 24	2.64
Jun 24	3.05
Jun 24	3.11
Jun 24	3.08
May 24	3.17
May 24	3
May 24	2.96
May 24	2.93
May 24	2.98

Price/Operating Cashflow

SANN.SW Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Mar 26	29.83
Mar 26	27.75
Mar 26	30.34
Mar 26	30.07
Feb 26	33.21
Feb 26	31.44
Feb 26	32.03
Feb 26	25.82
Jan 26	24.84
Jan 26	27.2
Jan 26	24.56
Jan 26	28.89
Dec 25	24.76
Dec 25	25.31
Dec 25	24.25
Dec 25	23.97
Dec 25	23.97
Nov 25	23.97
Nov 25	23.86
Nov 25	20.83
Nov 25	20.04
Oct 25	20.04
Oct 25	19.85
Oct 25	20.44
Oct 25	20.36
Oct 25	21.22
Sep 25	10.54
Sep 25	13.78
Sep 25	14.34
Sep 25	13.82
Aug 25	13.39
Aug 25	14.05
Aug 25	13.28
Aug 25	12.71
Jul 25	14.46
Jul 25	13.78
Jul 25	13.59
Jul 25	11.84
Jul 25	11.68
Jun 25	11.63
Jun 25	11.45
Jun 25	11.84
Jun 25	13.45
May 25	12.66
May 25	11.98
May 25	12.48
May 25	12.79
May 25	14.25
Apr 25	14.4
Apr 25	13.78
Apr 25	12.44
Apr 25	12.48
Mar 25	11.98
Mar 25	12.03
Mar 25	12.06
Mar 25	12.12
Feb 25	13.07
Feb 25	12.93
Feb 25	13.18
Feb 25	13.28
Jan 25	13.76
Jan 25	12.2
Jan 25	11.25
Jan 25	11
Jan 25	11.62
Dec 24	10.21
Dec 24	8.41
Dec 24	7.44
Dec 24	6.46
Nov 24	6.59
Nov 24	6.43
Nov 24	6.67
Nov 24	6.95
Nov 24	7.05
Oct 24	7.31
Oct 24	7.39
Oct 24	7.36
Oct 24	7.27
Sep 24	5.66
Sep 24	5.9
Sep 24	5.85
Sep 24	5.9
Aug 24	5.76
Aug 24	5.76
Aug 24	5.63
Aug 24	5.81
Aug 24	5.66
Jul 24	5.91
Jul 24	5.98
Jul 24	5.37
Jul 24	5.31
Jun 24	5.32
Jun 24	6.08
Jun 24	6.21
Jun 24	6.15
May 24	6.32
May 24	5.99
May 24	5.92
May 24	5.87
May 24	5.96

Price to Book

SANN.SW Price to Book by quarter
Period	Price to Book
Sep 25	4.47
Sep 25	5.84
Sep 25	6.08
Sep 25	5.86
Aug 25	5.68
Aug 25	5.96
Aug 25	5.63
Aug 25	5.39
Jul 25	6.13
Jul 25	5.84
Jul 25	5.76
Jul 25	5.02
Jul 25	4.95
Jun 25	4.93
Jun 25	4.86
Jun 25	5.02
Jun 25	5.7
May 25	5.37
May 25	5.08
May 25	5.29
May 25	5.42
May 25	6.04
Apr 25	6.11
Apr 25	5.84
Apr 25	5.28
Apr 25	5.29
Mar 25	3.51
Mar 25	3.53
Mar 25	3.54
Mar 25	3.56
Feb 25	3.84
Feb 25	3.79
Feb 25	3.87
Feb 25	3.9
Jan 25	4.04
Jan 25	3.58
Jan 25	3.3
Jan 25	3.23
Jan 25	3.41
Dec 24	3
Dec 24	2.47
Dec 24	2.18
Dec 24	1.9
Nov 24	1.93
Nov 24	1.89
Nov 24	1.96
Nov 24	2.04
Nov 24	2.07
Oct 24	2.14
Oct 24	2.17
Oct 24	2.16
Oct 24	2.13
Sep 24	1.65
Sep 24	1.72
Sep 24	1.7
Sep 24	1.72
Aug 24	1.68
Aug 24	1.68
Aug 24	1.64
Aug 24	1.69
Aug 24	1.65
Jul 24	1.72
Jul 24	1.74
Jul 24	1.56
Jul 24	1.54
Jun 24	1.55
Jun 24	1.77
Jun 24	1.81
Jun 24	1.79
May 24	1.84
May 24	1.74
May 24	1.72
May 24	1.71
May 24	1.73
Apr 24	1.77
Apr 24	1.7
Apr 24	1.72
Apr 24	1.77
Sep 22	30.99
Sep 22	31.33
Sep 22	31.37
Sep 22	30.99
Aug 22	25.2
Aug 22	27.37
Aug 22	29.87
Aug 22	31.93
Jul 22	30.99
Jul 22	31.7
Jul 22	32.97
Jul 22	33.61
Jul 22	31.44
Jun 22	37.34
Jun 22	38.83
Jun 22	39.58
Jun 22	43.17
May 22	49.66
May 22	49.66
May 22	47.42
May 22	50.63
Apr 22	47.8

No video analysis for this stock yet. Request one from our team.

News: SANN.SW

globenewswire.com · 1 Jul 2026

Santhera Notes Topline Results from Catalyst Pharmaceuticals’ Phase 1 Clinical Study of AGAMREE®

Data support AGAMREE's potential use as a treatment across a broad range of chronic inflammatory rare diseases Pratteln, Switzerland, July 1, 2026 - Santhera Pharmaceuticals (SIX: SANN) today notes topline results from a two-part Phase 1 clinical study of AGAMREE conducted by its North American licensing partner, Catalyst Pharmaceuticals, Inc.

globenewswire.com · 1 Jul 2026

Santhera gibt Topline-Ergebnisse der klinischen Phase-1-Studie von Catalyst Pharmaceuticals zu AGAMREE® bekannt

Die Daten untermauern das Potenzial von AGAMREE als Therapie für ein breites Spektrum chronisch-entzündlicher seltener Erkrankungen Pratteln, Schweiz, 1. Juli 2026 - Santhera Pharmaceuticals (SIX: SANN) gibt heute die Topline-Ergebnisse einer zweiteiligen klinischen Phase-1-Studie zu AGAMREE bekannt, die von seinem nordamerikanischen Lizenzpartner Catalyst Pharmaceuticals, Inc.

AI Analysis

Santhera Pharmaceuticals Holding AG

Video analysis: SANN.SW

News: SANN.SW

Santhera Notes Topline Results from Catalyst Pharmaceuticals’ Phase 1 Clinical Study of AGAMREE®

Santhera gibt Topline-Ergebnisse der klinischen Phase-1-Studie von Catalyst Pharmaceuticals zu AGAMREE® bekannt

Similar companies